Naoko Takeuchi

Dr. Naoko Takeuchi

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2023 in Oncology
Verified
Journal Article
Closed access
PDF file
MOMegumu Osaki
Megumu Osaki
TAToru Arai
Toru Arai
HSHiromitsu Sumikawa
Hiromitsu Sumikawa
TTTakayuki Takimoto
Takayuki Takimoto
NTNaoko Takeuchi
Naoko Takeuchi
YIYoshikazu Inoue
Yoshikazu Inoue
Introduction: Pleuroparenchymal fibroelastosis (PPFE) findings are associated with poor prognosis in interstitial lung disease (ILD). However, the effect of PPFE findings on the development of immune checkpoint inhibitor-related pneumonitis (ICI-pneumonitis), a life-threatening adverse event, in lung cancer patients with ILD has not been elucidated. We aimed to determine whether PPFE findings are a risk factor for ICI-pneumonitis in lung cancer patients with ILD. Methods: We retrospectively examined 712 lung cancer patients, including 173 patients with background ILDs, who received ICI therapy in our institute between December 2015 and May 2021. Background ILDs were radiologically classified into three types: lone PPFE, other ILDs with PPFE, and other ILDs without PPFE. The cumulative ICI-pneumonitis incidence curves and median overall survival (mOS) were compared between the three radiological types, and risk factors for ICI-pneumonitis were evaluated. Results: Of 173 eligible patients with ILD, 23 patients (13.3%) experienced ICI-pneumonitis. The Kaplan-Meier method and the log-rank test showed that lone PPFE patients had significantly lower incidence of ICI-pneumonitis (p = 0.024) and longer mOS (575 vs. 326 days; p = 0.0096) than other ILDs patients. ICI-pneumonitis (p = 0.35) and mOS (p = 0.29) were not significantly different between other ILDs with and without PPFE. A multivariate Cox proportional hazards regression analysis revealed that lone PPFE pattern was an independent predictive factor for ICI-pneumonitis (hazard ratio, 0.20; 95% confidence interval, 0.043–0.93; p = 0.040). Conclusion: ICI therapy could be safer in lone PPFE patients than in other ILDs patients with lung cancer.

1 January 2017 in Internal Medicine
Verified
Journal Article
Open access
PDF file
TTTaisuke Tsuji
Taisuke Tsuji
SSShoko Sonobe
Shoko Sonobe
TKTaro Koba
Taro Koba
TMToshiya Maekura
Toshiya Maekura
NTNaoko Takeuchi
Naoko Takeuchi
KTKazunobu Tachibana
Kazunobu Tachibana
A 51-year-old man was admitted to have a nodule evaluated using chest computed tomography (CT). Shortly after curetting and transbronchial biopsies via bronchoscopy, hypotension, bradycardia, unconsciousness, and left hemiplegia appeared and resolved within one hour. Head CT showed cerebral air embolism. The following day, lower left quadrant pain developed. Pneumatosis intestinalis on abdominal CT and elevation of creatine kinase and troponin T levels indicated air embolism in the mesenteric and coronary arteries. Some reports have documented cerebral air embolism alone after bronchoscopy; however, we should consider systemic air embolism, even when encountering a patient without specific symptoms related to any organ.

30 November 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TAToru Arai
Toru Arai
TTTakayuki Takimoto
Takayuki Takimoto
NTNaoko Takeuchi
Naoko Takeuchi
SMShojiro Minomo
Shojiro Minomo
TKTomoko Kagawa
Tomoko Kagawa
YIYoshikazu Inoue
Yoshikazu Inoue
Background: This study aimed to clarify the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF). Methods: Eighty-six patients diagnosed with AE-IPF were included in this single-center retrospective study. The NLR was calculated by dividing the peripheral neutrophil count by the peripheral lymphocyte count. The cut-off values of the NLR for predicting 90-day survival were determined using receiver operating characteristic curve analysis. Oxygenation deterioration on days 4 and 8 relative to that on day 1 was clinically defined. The prognostic value of NLR was evaluated using Cox proportional hazard regression analysis. Results: The cut-off value of day-1, day-4, and day-8 NLRs for predicting 90-day survival was 12.13, 14.90, and 10.56, respectively. A higher day-1 NLR was a significant predictor of a poor prognosis in univariate and multivariate analyses. Survival was significantly better in patients without oxygenation deterioration on days 4 and 8 than in those with deterioration. Day-4 and day-8 NLR could predict 90-day survival in patients without oxygenation deterioration. Conclusions: Day-1 NLR was a useful predictor of 90-day survival in AE-IPF. Further, monitoring day-4 and day-8 NLRs and evaluating oxygenation deterioration may be useful for managing AE-IPF.

7 June 2021 in Turkish Thoracic Journal
Verified
Journal Article
Closed access
TETakatoshi Enomoto
Takatoshi Enomoto
YMYoshinobu Matsuda
Yoshinobu Matsuda
YAYuichi Adachi
Yuichi Adachi
SKShunichi Kouno
Shunichi Kouno
YIYuji Inagaki
Yuji Inagaki
YIYoshikazu Inoue
Yoshikazu Inoue
Capnography,carbon dioxide,blood gas analysis,interstitial lung disease

15 February 2022 in Internal Medicine
Verified
Journal Article
Open access
PDF file
KKKanako Katayama
Kanako Katayama
TAToru Arai
Toru Arai
TKTakehiko Kobayashi
Takehiko Kobayashi
SSSayoko Shintani
Sayoko Shintani
NTNaoko Takeuchi
Naoko Takeuchi
YIYoshikazu Inoue
Yoshikazu Inoue
Airway-centered fibroelastosis is a distinct entity characterized by prominent airway-centered elastosis of the upper lobe with little or no pleural involvement. Little is known regarding its etiology; however, it was reported to have an idiopathic or asthma-associated etiology. We document, for the first time, 2 women (19 and 60 years old) who developed pleuroparenchymal fibroelastosis with a predominantly airway-centered distribution as a late complication (6 and 9 years later, respectively) of chemotherapy. The disease rapidly progressed following the manifestation of symptoms, and they subsequently died (3 and 2 years later, respectively). Therefore, post-chemotherapy long-term monitoring for this disease is warranted.

30 July 2024 in Respiratory Investigation
Verified
Journal Article
Closed access
MMMitsuhiro Moda
Mitsuhiro Moda
HSHiromitsu Sumikawa
Hiromitsu Sumikawa
RSRyota Shintani
Ryota Shintani
NTNaoko Takeuchi
Naoko Takeuchi
TKTomoko Kagawa
Tomoko Kagawa
TAToru Arai
Toru Arai